[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.111.118. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 1992

Radiation Therapy of Acquired Immunodeficiency Syndrome-Related Kaposi's Sarcoma of the Eyelids and Conjunctiva

Author Affiliations

From the Francis I. Proctor Foundation (Drs Ghabrial, Dunn, and Char), the Ocular Oncology Unit, Department of Ophthalmology (Dr Char), and the Department of Radiation Oncology (Drs Quivey and Char), the University of California, San Francisco.

Arch Ophthalmol. 1992;110(10):1423-1426. doi:10.1001/archopht.1992.01080220085027
Abstract

• We retrospectively studied 42 men with acquired immunodeficiency syndrome-related Kaposi's sarcoma of the conjunctiva or eyelids who were treated with radiation. Forty-nine sites were treated, 35 (71%) of which involved the eyelids, 12 (24%) the conjunctiva, and two (4%) both the eyelids and conjunctiva. Group 1 consisted of 31 sites treated with a single dose of 800 cGy and group 2 consisted of 18 sites treated with a multiple-fraction regimen and total doses between 1500 and 3600 cGy. The response and recurrence rates in the two groups were similar. One patient from group 2 died within 1 month of treatment and was not included in the analysis. The lesions improved in all cases. A complete response was obtained in 10 (32%) of the 31 lesions in group 1, compared with four (22%) of 18 lesions in group 2. A partial response was obtained in 21 (68%) of 31 lesions in group 1, compared with 13 (72%) of 18 lesions in group 2. Expected minor reactions in the treatment field, primarily loss of cilia, were comparable in the two groups. No serious complications were noted. Recurrence occurred in seven (22%) of the 31 sites in group 1 (six patients) and seven (39%) of the 18 sites in group 2 (six patients). The results subgest that a single treatment of 800 cGy is a safe and effective palliative therapy for ophthalmic acquired immunodeficiency syndrome-related Kaposi's sarcoma.

References
1.
Rutherford GW, Payne SF, Lemp GF.  The epidemiology of AIDS-related Kaposi's sarcoma .J AIDS . 1990;3( (suppl) ):924-931.
2.
AIDS Weekly Surveillance Report. Atlanta, Ga: United States AIDS Program, Center for Infectious Diseases, Centers for Disease Control; August 1, 1988.
3.
Haverkes HW, Friedman-Kien AE, Drotman DP, Morgan WM.  The changing incidence of Kaposi sarcoma amongst patients with AIDS . J Am Acad Dermatol . 1990;22:1250-1253.Article
4.
Centers for Disease Control.  Update: acquired immunodeficiency syndrome and human immunodeficiency virus infection in the United States . MMWR . 1989;38:1-4.
5.
Friedman-Kien AE, Saltzman BR.  Clinical manifestations of classical, endemic African, and epidemic AIDS-related Kaposi's sarcoma . J Am Acad Dermatol . 1990:22:1237-1250.
6.
Berson AM, Quivey JM, Harris JW, Wara WM.  Radiation therapy for AIDS-related Kaposi's sarcoma . Int J Radiat Oncol Biol Phys . 1990;19:569-575.Article
7.
Cooper JS, Fried PR.  Defining the role of radiation therapy in the management of epidemic Kaposi's sarcoma . Int J Radiat Oncol Biol Phys . 1987;3:35-39.Article
8.
Cooper JS, Fried PR.  Treatment of aggressive epidemic Kaposi's sarcoma of the conjunctiva by radiotherapy . Arch Ophthalmol . 1988;106:20-21.Article
9.
Cooper JS.  Optimal treatment of epidemic Kaposi's sarcoma . Int J Radiat Oncol Biol Phys . 1990;19:807-808.Article
10.
Shuler JD, Holland GN, Miles SA, Miller BJ, Grossman I.  Kaposi sarcoma of the conjunctiva and eyelids associated with the acquired immunodeficiency syndrome . Arch Ophthalmol . 1989;107:858-862.Article
11.
Volberding P.  Therapy of Kaposi's sarcoma in AIDS . Semin Oncol . 1984;11:60-67.
12.
Mitsuyuasu RT, Groopman JE.  Biology and therapy of Kaposi's sarcoma . Semin Oncol . 1984;11:54-59.
13.
Krown SE, Real FX, Vadhan-Raj S, et al.  Kaposi's sarcoma and the acquired immune deficiency syndrome: treatment with recombinant interferon alpha and analysis of prognostic factors . Cancer . 1986;57:1662-1665.Article
14.
Mitsayasu RT, Taylor JMG, Glaspy J, Fahey JL.  Heterogeneity of epidemic Kaposi's sarcoma: implications for therapy . Cancer . 1986;57:1657-1661.Article
15.
Macher AM, Palestine A, Masur H, et al.  Multicentric Kaposi's sarcoma of the conjunctiva in a male homosexual with the acquired immunodeficiency syndrome . Ophthalmology . 1983;90:879-884.Article
16.
Schag CC, Heinrich RL, Ganz PA.  Karnofsky performance status revisited: reliability, validity, and guidelines . J Clin Oncol . 1984;2:187-194.
17.
Lo TCM, Salzman FA, Smedal MI, Wright KA.  Radiotherapy for Kaposi's sarcoma . Cancer . 1980;45:684-687.Article
18.
Cooper JS.  The influence of dose on the long-term control of classic (non-AIDS associated) Kaposi's sarcoma by radiotherapy . Int J Radiat Oncol Biol Phys . 1988;15:1141-1146.Article
×